Rodman J H, Jelliffe R W, Kolb E, Tuey D B, de Guzman M F, Wagers P W, Haywood L J
Arch Intern Med. 1984 Apr;144(4):703-9.
A randomized prospective study compared achievement and maintenance of therapeutic plasma concentrations in patients receiving computer-assisted (CA) initial lidocaine hydrochloride therapy, designed pharmacokinetically to achieve and maintain a chosen plasma concentration, v conventional lidocaine therapy (CT). A separate audit of outcome was also conducted. The CA regimens provided more effective concentrations in the first hour than did CT, 2.65 v 1.5 micrograms/mL average. In the audit, ventricular fibrillation occurred in two of 78 CA v eight of 78 CT patients. Dosage adjustments were required in two CA patients v 33 CT patients. The CA therapy improved therapeutic precision, reduced dosage adjustments, and may have improved safety during initial lidocaine therapy before fitting to plasma concentration data for subsequent feedback. An improved clinical computer program now also fits to plasma concentration data. It is accessed and used routinely by hospitals over an international time-sharing network.
一项随机前瞻性研究比较了接受计算机辅助(CA)初始盐酸利多卡因治疗的患者与接受传统利多卡因治疗(CT)的患者达到并维持治疗性血浆浓度的情况。CA初始盐酸利多卡因治疗是根据药代动力学设计的,目的是达到并维持选定的血浆浓度。还对结果进行了单独审核。在第一个小时内,CA方案提供的血浆浓度比CT更有效,平均分别为2.65微克/毫升和1.5微克/毫升。在审核中,78例接受CA治疗的患者中有2例发生心室颤动,而78例接受CT治疗的患者中有8例发生心室颤动。2例接受CA治疗的患者需要调整剂量,而接受CT治疗的患者中有33例需要调整剂量。在根据血浆浓度数据进行调整以获得后续反馈之前,CA治疗提高了治疗的精确性,减少了剂量调整次数,并且可能提高了初始利多卡因治疗期间的安全性。现在,一个改进的临床计算机程序也可以根据血浆浓度数据进行调整。各医院通过一个国际分时网络可以常规访问和使用该程序。